VABYSMO™ (faricimab-svoa) | Wet AMD, DME and RVO Treatment
VABYSMO™ (faricimab-svoa) is the only FDA-approved treatment designed to block 2 causes of wet AMD, DME and RVO. See full safety for more information.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 97.377 |
| 2025-03 | 121.52 |
| 2025-04 | 85.983 |
| 2025-05 | 94.415 |
| Source | Traffic Share |
|---|---|
| search | 52.95% |
| direct | 25.90% |
| paid referrals | 7.85% |
| referrals | 7.23% |
| social | 5.97% |
| 0.09% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| vabysmo | 1,413 | 14,130 | $8.55 |
| wet amd treatment | 128 | 1,280 | $6.95 |
| vabysmo patient information | 3 | 30 | $0.00 |